Concourse Financial Group Securities’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-35
Closed -$654 2432
2022
Q4
$685 Hold
35
﹤0.01% 2215
2022
Q3
$1K Sell
35
-10
-22% -$202 ﹤0.01% 1932
2022
Q2
$1K Buy
45
+2
+5% +$47 ﹤0.01% 2141
2022
Q1
$1K Sell
43
-11
-20% -$302 ﹤0.01% 2128
2021
Q4
$1K Buy
54
+3
+6% +$85 ﹤0.01% 2324
2021
Q3
$1K Sell
51
-11
-18% -$294 ﹤0.01% 2352
2021
Q2
$2K Hold
62
﹤0.01% 2219
2021
Q1
$1K Buy
62
+10
+19% +$205 ﹤0.01% 2284
2020
Q4
$1K Buy
+52
New +$935 ﹤0.01% 2233
2020
Q2
Sell
-100
Closed -$1.49K 2246
2020
Q1
$1K Hold
100
﹤0.01% 2084
2019
Q4
$2K Hold
100
﹤0.01% 1921
2019
Q3
$2K Hold
100
﹤0.01% 1571
2019
Q2
$2K Hold
100
﹤0.01% 2034
2019
Q1
$2K Buy
+100
New +$2.33K ﹤0.01% 2068

Other funds holding TBI

Concourse Financial Group Securities's TBI Position: Q1 2023 in Review

Concourse Financial Group Securities sold out of Trueblue (TBI) in Q1 2023, closing a stake of 35 shares — an estimated $654 sold.

Concourse Financial Group Securities first reported a position in TBI in Q1 2019 and held it in 14 quarters. The position peaked at $2K in Q2 2021. 156 funds tracked by Wall St. Rank hold TBI as of Q1 2023.

  • Concourse Financial Group Securities reported no remaining Trueblue position as of Q1 2023 after selling out during the quarter.
  • Concourse Financial Group Securities sold 35 Trueblue shares in Q1 2023, an estimated $654.
  • Concourse Financial Group Securities first reported a position in Trueblue in Q1 2019 and held it in 14 quarters.
  • Concourse Financial Group Securities's Trueblue position peaked at $2K in Q2 2021.
  • 156 funds tracked by Wall St. Rank held Trueblue as of Q1 2023.

Based on Concourse Financial Group Securities's 13F filing for Q1 2023, filed 15 May 2023.